23-312-200

Roche Diagnostics cobas™ liat Influenza A/B + RSV Multiplex Assay

Manufacturer: Roche Diagnostics

Select a Size

Pack Size SKU Availability Price
Each of 1 23-312-200-Each-of-1 In Stock ₹ 1,51,013.40

23-312-200 - Each of 1

₹ 1,51,013.40

In Stock

Quantity

1

Base Price: ₹ 1,51,013.40

GST (18%): ₹ 27,182.412

Total Price: ₹ 1,78,195.812

Accuracy

Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%

Content And Storage

36°F to 46°F

CPT Code

87631

Clia Complexity

Waived

Format

Case (Kit)

Sensitivity

Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%

Packaging Type

Case (kit)

Specificity

Negative Agreement: Influenza A 96.5%; Influenza B 99.4%; RSV 98.4%

Certifications/Compliance

None

Control Sets

Controls purchases separately (FCAT# 23312203)

CE Marker

No

Detectable Analytes

Influenza A and B, Respiratory Syncytial Virus (RSV) RNA

Sample Type

Nasopharyngeal

Type

Nucleic Acid RT-PCR Influenza A, Influenza B, RSV

Quantity

20 Tests/Cs. (Kit)

Test Time

20 min.

Related Products

Img

Roche Diagnostics

21-200-318

--

Img

Roche Diagnostics

21-200-319

--

Img

Germaine™ Laboratories

23-900-207

--

Img

Germaine™ Laboratories

23-111-441

--

Img

SEKISUI Diagnostics™

22-321-128

--

Img

Roche Diagnostics

23-312-207

--

Img

Fischer Scientific

22-321-105

--

Img

Quidel

23-044-155

--

Description

  • No patient age restrictions for test Testing accuracy with RT-PCR technology Definitive results with no need for interpretation or confirmation Fast, easy operation Three easy steps Results in 20 minutes

SAFETY INFORMATION

  • ShelfLife : 150 Days